Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm   
Email ID
Password
Sign me in automatically next time
Home - Comment
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK Promote your vacancy here
AstraZeneca's blockbuster atypical antipsychotic Seroquel (quetiapine) has been in the news quite a bit these days in relation to the multi-million-dollar settlements of its off-label probes in the US. This week, the UK's self-regulatory body for ...
A Scrip analysis has identified 21 companies that raised private investment in July, one up on the previous month, but a 41% increase in the funds raised to $540 million compared with June. . The increase was largely due to two of the highest ...
While the UK's NHS and pharma sector ponder who may end up negotiating drug prices in light of a new white paper, health economists Stuart Carroll, Neil Hawkins and David A Scott contemplate four options which keep NICE very much in the picture ...
The UK's Sunday Times newspaper, in collaboration with FastTrack, last month published its annual Top Track 100 league table of the top 100 private companies in the UK with the greatest sales. Unsurprisingly, pharma and biotech companies were ...
 
German or Spanish physicists hoping for a career change involving a move to London at the end of the year and taking charge of the European Medicines Agency have had their hopes dashed. It turns out, not surprisingly, that the person who will ...
Public health authorities now have the green light to offer financial incentives to doctors for prescribing lower-cost drugs, thanks to a European Court of Justice ruling on EU advertising legislation. This seems rather bizarre given that the same ...
Logos are said to be an important part of an organisation's branding. Really good logos contribute to an organisation's visibility, credibility and memorability, so say branding experts. The logo of the most famous of the medicines regulators, the ...
Emerging marketsare a popular topic at the moment, with pharma firms seeking sales growth outside the mature and slowing markets of the west. There are some companies with a long history of participating in these markets, such as AstraZeneca, which ...
 
Taiwan's efforts to reform its financially struggling national health insurance (NHI) scheme go back at least four years, but political debate over what form the "second generation" of the programme should take is now coming to a long-delayed head. ...
The arrival of NDM-1, a new "superbug" that is resistant to most antibiotics, is the latest in a succession of health scares, many of which proved to be far less serious than expected. Is this new threat any different, or are we in danger of ...
Transparency is everything – or so it would appear. Barely a week goes by without new proposals to put more information into the public domain, set new conditions for experts sitting on advisory committees, or limit companies' freedom to hand out ...
Just as WHO delegates were sitting down to a press conference in Hong Kong this week to announce that the world was finally reverting to seasonal influenza characteristics and patterns of transmission, another global infection scare was hitting the ...
 
COMPANY/ORGANISATION
CONDITION
GEOGRAPHY
DRUG
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36